Reactive oxygen species in tumor necrosis factor-alpha-activated primary human keratinocytes: implications for
Chen N Young1, Jay I Koepke2, Laura J Terlecky3
1Department of Dermatology, Wayne State University School of Medicine, Detroit, Michigan, USA.
Abstract:
The multifunctional cytokine tumor necrosis factor-alpha (TNF-alpha) is known to play an important role in inflammatory and immunological responses in human skin. Although it has been documented that reactive oxygen species (ROS) are involved in TNF-alpha-induced signaling pathways associated with certain inflammatory diseases, their role in TNF-alpha signaling cascades has not been examined in primary human keratinocytes used as a model of inflammatory skin disease and psoriasis. Employing a series of in vitro and in cellulo approaches, we have demonstrated that in primary human keratinocytes (i) TNF-alpha rapidly induces ROS generation, IkappaB degradation, NF-kappaB p65 nuclear translocation, and ultimately production of inflammatory cytokines; (ii) TNF-alpha-induced cytokine production is mediated both by the mammalian target of rapamycin signaling pathway via NF-kappaB activation and by ROS; (iii) TNF-alpha-dependent NF-kappaB activation (that is, IkappaB degradation and NF-kappaB p65 nuclear translocation) is not mediated by ROS; and (iv) a cell-penetrating derivative of the antioxidant enzyme, catalase, as well as taurine and N-acetyl-cysteine attenuate the TNF-alpha-induced production of cytokines. These latter results suggest that catalase and perhaps other antioxidants should be considered as part of a more specific and effective therapy for the treatment of inflammatory skin diseases, including psoriasis.
Insights
Tumor necrosis factor-alpha (TNF-alpha) rapidly triggers reactive oxygen species (ROS) and inflammatory cytokine production in human skin cells. Antioxidants like catalase show promise in treating inflammatory skin diseases such as psoriasis.
Area of Science:
- Dermatology
- Immunology
- Cell Biology
Background:
- Tumor necrosis factor-alpha (TNF-alpha) is a key cytokine in skin inflammation.
- Reactive oxygen species (ROS) are implicated in TNF-alpha signaling, but their role in keratinocytes is unclear.
- Primary human keratinocytes serve as a model for inflammatory skin diseases like psoriasis.
Purpose of the Study:
- To investigate the role of ROS in TNF-alpha signaling pathways in human keratinocytes.
- To elucidate the mechanisms of TNF-alpha-induced inflammatory cytokine production.
- To explore the therapeutic potential of antioxidants in inflammatory skin conditions.
Main Methods:
- In vitro and in cellulo experiments using primary human keratinocytes.
- Analysis of TNF-alpha-induced ROS generation, IkappaB degradation, and NF-kappaB p65 nuclear translocation.
- Assessment of cytokine production and the effects of antioxidants (catalase, taurine, N-acetyl-cysteine).
Main Results:
- TNF-alpha rapidly induced ROS generation, IkappaB degradation, NF-kappaB p65 nuclear translocation, and inflammatory cytokine production.
- TNF-alpha-induced cytokine production was mediated by mammalian target of rapamycin (mTOR) signaling via NF-kappaB and by ROS.
- TNF-alpha-dependent NF-kappaB activation was independent of ROS.
- Antioxidants attenuated TNF-alpha-induced cytokine production.
Conclusions:
- ROS play a significant role in TNF-alpha-induced inflammatory cytokine production in keratinocytes.
- TNF-alpha signaling involves both NF-kappaB and ROS-dependent pathways.
- Antioxidants, particularly catalase, show potential for treating inflammatory skin diseases like psoriasis.
Related Concept Videos
T Cell Types and Functions
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
Bioactivation and Tissue Toxicity
NF-κB-dependent Signaling Pathway
NF-κB-dependent Signaling Mechanism
The heterodimer of NF-κB...
Radical Autoxidation
Electron Transport Chain: Complex I and II
ROS generation is regulated and maintained at moderate levels necessary...
Skin Cancer
Basal Cell Carcinoma (BCC): BCC is the most common type of skin cancer, accounting for about 80% of cases. It typically develops in...

